Skip to main content
. 2018 Jan 9;8(1):6. doi: 10.3390/bios8010006

Figure 5.

Figure 5

Nanoplasmonic inhibition assay for D3R-antagonist antipsychotic drug. (A) Sensorgrams obtained for indirect detection of buspirone at different concentrations (5 nM–5 mM). (B) Standard dose-response inhibition curve for indirect detection of Buspirone. Plots represent mean and standard deviation of each buspirone concentration (1 nM–5 mM) measured in triplicate. (C) Sensorgrams obtained for negative control drugs (i.e., etoposide and APAP), compared to pure D3R-AuNPs detection. (D) Signal comparison between dopamine, antipsychotic drugs, and control drugs at the same concentration (6.5 μM). Statistical analysis (n = 5) confirmed that differences between control drugs signals and free D3R are not significant (p < 0.05).